UK Markets open in 3 hrs 13 mins

2022 Clinical Trials Analysis Report: Clinical Trials Planned to Initiate in 2022, Clinical Trials Estimated to Complete in 2022, Spotlight on COVID-19 Clinical Trials

·2-min read
Company Logo
Company Logo

Dublin, May 13, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trials in 2022 - A Preview of Trials Planned to Initiate and Estimated to Complete in 2022" report has been added to ResearchAndMarkets.com's offering.

This report provides a preview of clinical trials that are planned to be initiated and projected to be completed in 2022.

Scope

  • The clinical trials data used for these analyses were extracted from the publisher's Clinical Trials Database. The data included planned clinical trials with a start date from January 1 to December 31, 2022, captured in the database as of December 20, 2021.

  • The planned trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials. Clinical trials with an ongoing or planned status with an end date between January 1 and December 31, 2022, were also examined.

  • The trials that are estimated to be completed in 2022 were split by phase, status, indication, sponsor type, top sponsors, and geography. Additional analyses were completed for COVID-19 trials planned to be initiated or expected to be completed in 2022. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.

Reasons to Buy

  • Understand the planned trials landscape and trends for 2022

  • Provide early insight for studies expected to be completed in 2022

  • The trends of rescue clinical trials with delayed estimated end date

  • Analyses for COVID-19 trials planned to be initiated or expected to be completed in 2022

Key Topics Covered:

Executive Summary

  • Introduction

  • Clinical Trials Planned to Initiate in 2022

  • Clinical Trials Estimated to Complete in 2022

  • Spotlight on COVID-19 Clinical Trials

  • Key Findings

Appendix

For more information about this report visit https://www.researchandmarkets.com/r/9640y2

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting